Finance

Lists
Why is 2181 up 3.03%?
Dive Deeper
2181:HKG
Mabpharm Ltd
HK$0.51
+3.03%
(+0.015) 1D
Sep 25, 3:59:20 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2181...
Mkt. cap
2.10B
Avg. vol.
41.67K
Volume
0.00
P/E ratio
21.04
52-wk high
HK$0.81
52-wk low
HK$0.31
EPS
HK$0.02
Shares outstanding
4.12B
No. of employees
394
Mkt. cap
2.10B
Avg. vol.
41.67K
Volume
0.00
P/E ratio
21.04
52-wk high
HK$0.81
52-wk low
HK$0.31
EPS
HK$0.02
Shares outstanding
4.12B
No. of employees
394
About Mabpharm Ltd
CEO-
Employees394
Founded2018
Headquarters-
SectorBiotechnology
Websitemabpharm.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
185.96M
185.96M
198.97M
198.97M
Cost of goods sold
19.75M
19.75M
18.19M
18.19M
Cost of revenue
19.75M
19.75M
18.19M
18.19M
Research and development expenses
16.86M
16.86M
12.97M
12.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
148.29M
148.29M
149.77M
149.77M
Operating expense
165.23M
165.23M
163.81M
163.81M
Total operating expenses
184.98M
184.98M
182.01M
182.01M
Operating income
971.00K
971.00K
16.96M
16.96M
Other non operating income
1.55M
1.55M
15.00K
15.00K
EBT including unusual items
631.00K
631.00K
15.68M
15.68M
EBT excluding unusual items
601.50K
601.50K
15.65M
15.65M
Income tax expense
-26.49M
-26.49M
-
-
Effective tax rate
-4,197.54%
-4,197.54%
-
-
Other operating expenses
-
-
-
-
Net income
27.12M
27.12M
15.68M
15.68M
Net profit margin
14.58%
14.58%
7.88%
7.88%
Earnings per share
-
-
-
-
Interest and investment income
94.00K
94.00K
111.00K
111.00K
Interest expense
-2.69M
-2.69M
-2.66M
-2.66M
Net interest expenses
-2.60M
-2.60M
-2.55M
-2.55M
Depreciation and amortization charges
-
-
-
-
EBITDA
14.57M
14.57M
30.49M
30.49M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps